XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 184 filers reported holding XENON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 2.73 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $147,000 | +86.1% | 16,075 | 0.0% | 0.05% | -34.2% |
| Q1 2018 | $79,000 | +75.6% | 16,075 | 0.0% | 0.08% | -2.6% |
| Q4 2017 | $45,000 | -4.3% | 16,075 | 0.0% | 0.08% | +290.0% |
| Q3 2017 | $47,000 | -7.8% | 16,075 | 0.0% | 0.02% | -13.0% |
| Q2 2017 | $51,000 | -20.3% | 16,075 | 0.0% | 0.02% | -46.5% |
| Q1 2017 | $64,000 | -62.6% | 16,075 | 0.0% | 0.04% | -62.3% |
| Q3 2016 | $171,000 | -53.8% | 16,075 | -10.0% | 0.11% | -55.1% |
| Q2 2016 | $370,000 | +153.4% | 17,869 | +11.2% | 0.25% | +133.0% |
| Q1 2016 | $146,000 | -99.9% | 16,075 | 0.0% | 0.11% | -21.0% |
| Q4 2015 | $178,000,000 | – | 16,075 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 850,000 | $15,215,000 | 3.58% |
| ACUTA CAPITAL PARTNERS, LLC | 412,500 | $7,384,000 | 2.66% |
| BVF INC/IL | 3,481,778 | $62,324,000 | 2.34% |
| Soleus Capital Management, L.P. | 708,117 | $12,675,000 | 2.28% |
| COMMODORE CAPITAL LP | 301,392 | $5,395,000 | 2.15% |
| DAFNA Capital Management LLC | 406,535 | $7,277,000 | 1.73% |
| Parkman Healthcare Partners LLC | 374,395 | $6,702,000 | 1.56% |
| Avoro Capital Advisors LLC | 3,650,000 | $65,335,000 | 1.13% |
| KNOTT DAVID M | 144,101 | $2,579,000 | 1.10% |
| Orbimed Advisors | 2,497,917 | $44,713,000 | 0.42% |